European Journal of Nutrition

, Volume 54, Issue 2, pp 205–214 | Cite as

Habitual consumption of coffee and green tea in relation to serum adipokines: a cross-sectional study

  • Ngoc Minh PhamEmail author
  • Akiko Nanri
  • Kazuki Yasuda
  • Kayo Kurotani
  • Keisuke Kuwahara
  • Shamima Akter
  • Masao Sato
  • Hitomi Hayabuchi
  • Tetsuya Mizoue
Original Contribution



Coffee and green tea consumption may be associated with circulating adipokines, but data are inconsistent, scarce or lacking. We examined the association of coffee and green tea consumption with serum adiponectin, leptin, visfatin, resistin and plasminogen activator inhibitor-1 (PAI-1) among a Japanese working population.


The authors analyzed data (n = 509) from a cross-sectional survey among Japanese workers aged 20–68 years. Serum adipokines were measured using a Luminex suspension bead-based multiplexed array. Coffee and green tea consumption was assessed using a validated diet history questionnaire, and caffeine consumption from these beverages was estimated. Multiple regression analysis was performed with adjustment for potential confounding variables.


Coffee consumption was significantly, inversely associated with leptin and PAI-1 (P for trend = 0.007 and 0.02, respectively); compared with subjects consuming <1 cup per day, those consuming ≥4 cups per day had 13 and 10 % lower means of leptin and PAI-1, respectively. Similar associations were observed for caffeine consumption (P for trend = 0.02 for both leptin and PAI-1). Additionally, we noted a significant positive association between coffee consumption and adiponectin in men (P for trend = 0.046), but not in women (P for trend = 0.43, P for interaction = 0.11). Moreover, there was a positive association between coffee consumption and resistin in current male smokers (P for trend = 0.01), but not in male non-smokers (P for trend = 0.35, P for interaction = 0.11). Green tea consumption was not associated with any adipokine.


Higher consumption of coffee and caffeine but not green tea was associated with lower serum levels of leptin and PAI-1 in Japanese adults.


Coffee Green tea Adipokines Japanese 



We are grateful to the study participants for their cooperation and participation. We also thank Seiko Miyazaki and Yasutaka Horiuchi (Kyushu University); Emi Tanaka, Youko Tsuruda, Misaki Hirose, Meishu Sai, Miho Isayama, Midori Sasaki, Mie Shimomura and Azumi Uehara (Fukuoka Women’s University); Yaeko Nagano (retired nurse); and Akiko Hayashi, Yu Teruyama, Kae Saito, Kayoko Washizuka and Yuho Mizoue (National Center for Global Health and Medicine) for their help in data collection. We extend our thanks to Kazuko Nagase and Dai Suzuki (Department of Metabolic Disorder, Diabetes Research Center, National Center for Global Health and Medicine) for their contributions to measurements of serum adipokines. This study was supported by a Grant-in-Aid for Scientific Research (B) (21390213) from the Japan Society for the Promotion of Science (To Dr Mizoue), a Grant-in-Aid for Young Scientists (B) (21790598) from the Ministry of Education, Culture, Sports, Science and Technology and a Grant of National Center for Global Health and Medicine (To Dr Nanri).

Conflict of interest


Supplementary material

394_2014_701_MOESM1_ESM.docx (29 kb)
Supplementary material 1 (DOCX 28 kb)


  1. 1.
    Cano-Marquina A, Tarin JJ, Cano A (2013) The impact of coffee on health. Maturitas 75:7–21CrossRefGoogle Scholar
  2. 2.
    Cabrera C, Artacho R, Giménez R (2006) Beneficial effects of green tea—a review. J Am Coll Nutr 25:79–99CrossRefGoogle Scholar
  3. 3.
    Jiang X, Zhang D, Jiang W (2014) Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 53:25–38CrossRefGoogle Scholar
  4. 4.
    Yu X, Bao Z, Zou J, Dong J (2011) Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11:96CrossRefGoogle Scholar
  5. 5.
    Yang G, Shu XO, Li H, Chow WH, Ji BT, Zhang X, Gao YT, Zheng W (2007) Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomark Prev 16:1219–1223CrossRefGoogle Scholar
  6. 6.
    Natella F, Scaccini C (2012) Role of coffee in modulation of diabetes risk. Nutr Rev 70:207–217CrossRefGoogle Scholar
  7. 7.
    Thielecke F, Boschmann M (2009) The potential role of green tea catechins in the prevention of the metabolic syndrome—a review. Phytochemistry 70:11–24CrossRefGoogle Scholar
  8. 8.
    Nkondjock A (2012) Coffee and cancers. In: Chu Y-F (ed) Coffee: emerging health effects and disease prevention, 1st edn. Wiley, Institute of Food Technologists, Ames, pp 197–209CrossRefGoogle Scholar
  9. 9.
    Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–439CrossRefGoogle Scholar
  10. 10.
    Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97CrossRefGoogle Scholar
  11. 11.
    Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179–188CrossRefGoogle Scholar
  12. 12.
    Chen GC, Qin LQ, Ye JK (2014) Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes Rev 15:134–142CrossRefGoogle Scholar
  13. 13.
    van Kruijsdijk RC, van der Wall E, Visseren FL (2009) Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomark Prev 18:2569–2578CrossRefGoogle Scholar
  14. 14.
    Danese E, Montagnana M, Minicozzi AM, Bonafini S, Ruzzenente O, Gelati M, De Manzoni G, Lippi G, Guidi GC (2012) The role of resistin in colorectal cancer. Clin Chim Acta 413:760–764CrossRefGoogle Scholar
  15. 15.
    Huang WS, Chen CN, Sze CI, Teng CC (2013) Visfatin induces stromal cell-derived factor-1 expression by beta1 integrin signaling in colorectal cancer cells. J Cell Physiol 228:1017–1024CrossRefGoogle Scholar
  16. 16.
    Gils A, Declerck PJ (2004) Plasminogen activator inhibitor-1. Curr Med Chem 11:2323–2334CrossRefGoogle Scholar
  17. 17.
    Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, Hu FB, Mantzoros CS (2008) Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 31:504–507CrossRefGoogle Scholar
  18. 18.
    Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M, Koenig W, Sundvall J, Bidel S, Kuha S, Tuomilehto J (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 91:950–957CrossRefGoogle Scholar
  19. 19.
    Imatoh T, Tanihara S, Miyazaki M, Momose Y, Uryu Y, Une H (2011) Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. Eur J Nutr 50:279–284CrossRefGoogle Scholar
  20. 20.
    Saito M, Nemoto T, Tobimatsu S, Ebata M, Le Y, Nakajima K (2011) Coffee consumption and cystatin-C-based estimated glomerular filtration rates in healthy young adults: results of a clinical trial. J Nutr Metab 2011:146865CrossRefGoogle Scholar
  21. 21.
    Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, van Dam RM (2011) Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J 10:93CrossRefGoogle Scholar
  22. 22.
    Yamashita K, Yatsuya H, Muramatsu T, Toyoshima H, Murohara T, Tamakoshi K (2012) Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes 2:e33CrossRefGoogle Scholar
  23. 23.
    Mure K, Maeda S, Mukoubayashi C, Mugitani K, Iwane M, Kinoshita F, Mohara O, Takeshita T (2013) Habitual coffee consumption inversely associated with metabolic syndrome-related biomarkers involving adiponectin. Nutrition 29:982–987CrossRefGoogle Scholar
  24. 24.
    Kotani K, Fujiwara S, Hamada T, Tsuzaki K, Sakane N et al (2008) Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: response to Williams et al. Diabetes Care 31:e46 (author reply e47)CrossRefGoogle Scholar
  25. 25.
    Rebello SA, Chen CH, Naidoo N, Xu W, Lee J, Chia KS, Tai ES, van Dam RM (2011) Coffee and tea consumption in relation to inflammation and basal glucose metabolism in a multi-ethnic Asian population: a cross-sectional study. Nutr J 10:61CrossRefGoogle Scholar
  26. 26.
    Lagiou P, Signorello LB, Mantzoros CS, Trichopoulos D, Hsieh CC, Trichopoulou A (1999) Hormonal, lifestyle, and dietary factors in relation to leptin among elderly men. Ann Nutr Metab 43:23–29CrossRefGoogle Scholar
  27. 27.
    Tsioufis C, Dimitriadis K, Vasiliadou C, Taxiarchou E, Vezali E, Tsiamis E, Stefanadis C, Kallikazaros I (2006) Heavy coffee consumption in conjunction with smoking is accompanied by increased inflammatory processes and impaired thrombosis/fibrinolysis system in essential hypertensive subjects. J Hum Hypertens 20:470–472CrossRefGoogle Scholar
  28. 28.
    Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P (2008) Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 27:363–370CrossRefGoogle Scholar
  29. 29.
    Westerterp-Plantenga MS, Lejeune MP, Kovacs EM (2005) Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 13:1195–1204CrossRefGoogle Scholar
  30. 30.
    Andreasson AN, Unden AL, Elofsson S, Brismar K (2012) Leptin and adiponectin: distribution and associations with cardiovascular risk factors in men and women of the general population. Am J Hum Biol 24:595–601CrossRefGoogle Scholar
  31. 31.
    Pham NM, Akter S, Kurotani K, Nanri A, Sato M, Hayabuchi H, Yasuda K, Mizoue T (2012) Serum 25-hydroxyvitamin D and markers of insulin resistance in a Japanese working population. Eur J Clin Nutr 66:1323–1328CrossRefGoogle Scholar
  32. 32.
    Wu H, Yu Z, Qi Q, Li H, Sun Q, Lin X (2011) Joint analysis of multiple biomarkers for identifying type 2 diabetes in middle-aged and older Chinese: a cross-sectional study. BMJ Open 1:e000191CrossRefGoogle Scholar
  33. 33.
    Kobayashi S, Murakami K, Sasaki S, Okubo H, Hirota N, Notsu A, Fukui M, Date C (2011) Comparison of relative validity of food group intakes estimated by comprehensive and brief-type self-administered diet history questionnaires against 16 d dietary records in Japanese adults. Public Health Nutr 14:1200–1211CrossRefGoogle Scholar
  34. 34.
    Science and Technology Agency (2005) Standard tables of food composition in japan, 5th revised. Printing Bureau of the Ministry of Finance, TokyoGoogle Scholar
  35. 35.
    Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O’Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504CrossRefGoogle Scholar
  36. 36.
    National Cholesterol Education Program (NCEP) Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106:3143–3421Google Scholar
  37. 37.
    Marques-Vidal P, Bochud M, Paccaud F, Mooser V, Waeber G, Vollenweider P (2010) Distribution of plasma levels of adiponectin and leptin in an adult Caucasian population. Clin Endocrinol (Oxf) 72:38–46CrossRefGoogle Scholar
  38. 38.
    Filkova M, Haluzik M, Gay S, Senolt L (2009) The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 133:157–170CrossRefGoogle Scholar
  39. 39.
    Ding Q, White SP, Ling C, Zhou W (2011) Resistin and cardiovascular disease. Trends Cardiovasc Med 21:20–27CrossRefGoogle Scholar
  40. 40.
    D’Avanzo B, La Vecchia C, Tognoni G, Franceschi S, Franzosi MG, Nobili A, Santoro L, Scarsi G (1993) Coffee consumption and risk of acute myocardial infarction in Italian males. GISSI-EFRIM. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto, Epidemiologia dei Fattori di Rischio del’Infarto Miocardico. Ann Epidemiol 3:595–604CrossRefGoogle Scholar
  41. 41.
    Klatsky AL, Koplik S, Kipp H, Friedman GD (2008) The confounded relation of coffee drinking to coronary artery disease. Am J Cardiol 101:825–827CrossRefGoogle Scholar
  42. 42.
    Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ, Montagnani M (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292:E1378–E1387CrossRefGoogle Scholar
  43. 43.
    Tian C, Ye X, Zhang R, Long J, Ren W, Ding S, Liao D, Jin X, Wu H, Xu S, Ying C (2013) Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARgamma-adiponectin pathway. PLoS One 8:e53796CrossRefGoogle Scholar
  44. 44.
    Lee MS, Kim CT, Kim Y (2009) Green tea (−)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann Nutr Metab 54:151–157CrossRefGoogle Scholar
  45. 45.
    Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71:356–358CrossRefGoogle Scholar
  46. 46.
    Sone T, Kuriyama S, Nakaya N, Hozawa A, Shimazu T, Nomura K, Rikimaru S, Tsuji I (2011) Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr Res 55:8326CrossRefGoogle Scholar
  47. 47.
    Antuna-Puente B, Feve B, Fellahi S, Bastard JP (2008) Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 34:2–11CrossRefGoogle Scholar
  48. 48.
    Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, Lee MK (2010) Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol 48:937–943CrossRefGoogle Scholar
  49. 49.
    Greenberg JA, Boozer CN, Geliebter A (2006) Coffee, diabetes, and weight control. Am J Clin Nutr 84:682–693Google Scholar
  50. 50.
    Skurk T, Alberti-Huber C, Herder C, Hauner H (2007) Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92:1023–1033CrossRefGoogle Scholar
  51. 51.
    Lopez-Garcia E, van Dam RM, Qi L, Hu FB (2006) Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 84:888–893Google Scholar
  52. 52.
    Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I (1997) Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46:860–867CrossRefGoogle Scholar
  53. 53.
    Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527–3561Google Scholar
  54. 54.
    Buscemi S, Verga S, Batsis JA, Tranchina MR, Belmonte S, Mattina A, Re A, Rizzo R, Cerasola G (2009) Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur J Clin Nutr 63:1200–1205CrossRefGoogle Scholar
  55. 55.
    Lee SA, Kallianpur A, Xiang YB, Wen W, Cai Q, Liu D, Fazio S, Linton MF, Zheng W, Shu XO (2007) Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomark Prev 16:2464–2470CrossRefGoogle Scholar
  56. 56.
    Rosner B (2010) Multisample inference. Fundamentals of biostatistics, 7th edn. Cengage Learning, Boston, pp 516–587Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Ngoc Minh Pham
    • 1
    Email author
  • Akiko Nanri
    • 1
  • Kazuki Yasuda
    • 2
  • Kayo Kurotani
    • 1
  • Keisuke Kuwahara
    • 1
  • Shamima Akter
    • 1
  • Masao Sato
    • 3
  • Hitomi Hayabuchi
    • 4
  • Tetsuya Mizoue
    • 1
  1. 1.Department of Epidemiology and Prevention, Center for Clinical SciencesNational Center for Global Health and MedicineTokyoJapan
  2. 2.Department of Metabolic Disorder, Diabetes Research CenterNational Center for Global Health and MedicineTokyoJapan
  3. 3.Department of Applied Biological Chemistry, Graduate School of Bioresource and Bioenvironmental SciencesKyushu UniversityFukuokaJapan
  4. 4.Graduate School of Nutrition and Health ScienceFukuoka Women’s UniversityFukuokaJapan

Personalised recommendations